法规动态
2026年9月17日•3 分钟阅读
FDA Grants ANDA Approval for ICATIBANT (ANDA213773)
FDA approved ANDA213773 for the subcutaneous injectable prescription drug ICATIBANT, manufactured by Alembic Pharmaceuticals.
法规动态
2026年9月17日•3 分钟阅读
FDA Approves Alembic’s Tretinoin 0.05% Topical Cream (ANDA214590)
The FDA has granted approval for Alembic’s prescription tretinoin 0.05% cream, submitted under ANDA214590.